Search

Your search keyword '"Frébourg, T."' showing total 237 results

Search Constraints

Start Over You searched for: Author "Frébourg, T." Remove constraint Author: "Frébourg, T."
237 results on '"Frébourg, T."'

Search Results

1. Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

3. Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

4. LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

7. Recommandations pour le diagnostic de prédisposition génétique au mélanome cutané et pour la prise en charge des personnes à risque

8. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort

14. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations

20. The contribution of germline rearrangements to the spectrum of BRCA2 mutations

29. HNPCC syndrome (Hereditary Non Polyposis Colon Cancer): identification and management

31. SFCE CO-09 - Syndrome CMMR-D : description clinique dans une série française

32. Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

34. 71P - Prospective analysis of CEA, CA19.9, circulating DNA (cDNA) and circulating tumor cells (CTC) in patients (pts) treated for a metastatic colorectal cancer (mCRC)_Results of COCA-COLON study

38. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis

40. CO.21 Intérêt de la recherche des mutations de TP53 chez les patients sans mutation de KRAS traités par cetuximab plus chimiothérapie pour un cancer colorectal métastatique

41. CO.20 Impact clinique des polymorphismes des récepteurs FcγRIIa/FcγRIIIa et des mutations KRAS dans les cancers colorectaux métastatiques traités par cetuximab et irinotecan

45. Identification et prise en charge du syndrome HNPCC (hereditary non polyposis colon cancer). Prédisposition héréditaire aux cancers du côlon, du rectum et de l'utérus

47. Hyperprolinemia is a risk factor for schizoaffective disorder

Catalog

Books, media, physical & digital resources